Ignite Creation Date:
2025-12-24 @ 1:50 PM
Ignite Modification Date:
2026-02-03 @ 5:19 PM
Study NCT ID:
NCT00069095
Status:
COMPLETED
Last Update Posted:
2016-10-06
First Post:
2003-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
Sponsor:
Organization: